Biphasic/JJ
control/NN
of/IN
nuclear/JJ
factor-kappa/NN
B/NN
activation/NN
by/IN
the/DT
T/NN
cell/NN
receptor/NN
complex/NN
:/:
role/NN
of/IN
tumor/NN
necrosis/NN
factor/NN
alpha/NN
./.

The/DT
regulation/NN
of/IN
nuclear/JJ
factor/NN
(/(
NF/NN
)/)
-kappa/NN
B/NN
activation/NN
by/IN
the/DT
T/NN
cell/NN
receptor/NN
(/(
TcR/NN
)/)
/CD3/NN
complex/NN
in/IN
primary/JJ
human/JJ
T/NN
cells/NNS
has/VBZ
been/VBN
studied/VBN
at/IN
various/JJ
times/NNS
after/IN
activation/NN
./.
=====
Only/RB
p50/NN
NF-kappa/NN
B/NN
protein/NN
bound/VBD
the/DT
kappa/NN
B/NN
element/NN
of/IN
interleukin-2/NN
receptor/NN
(/(
IL-2R/NN
)/)
alpha/NN
chain/NN
promoter/NN
on/IN
resting/VBG
T/NN
cells/NNS
./.
=====
However/RB
,/,
immediately/RB
after/IN
TcR/CD3/NN
cross-linking/JJ
(/(
after/IN
approximately/RB
1/CD
h/NN
;/:
immediate/JJ
)/)
binding/NN
of/IN
p50.p65/NN
heterodimers/NNS
was/VBD
observed/VBN
./.
=====
p50.c-rel/NN
heterodimers/NNS
were/VBD
also/RB
detected/VBN
bound/VBN
to/TO
this/DT
sequence/NN
at/IN
early/JJ
time/NN
points/NNS
(/(
7-16/CD
h/NN
;/:
early/RB
)/)
,/,
and/CC
both/DT
remained/VBD
active/JJ
at/IN
later/JJR
time/NN
points/NNS
(/(
40/CD
h/NN
;/:
late/RB
)/)
after/IN
activation/NN
./.
=====
This/DT
regulation/NN
takes/VBZ
place/NN
mainly/RB
at/IN
the/DT
level/NN
of/IN
nuclear/JJ
translocation/NN
of/IN
p65/NN
and/CC
c-rel/NN
,/,
at/IN
immediate/JJ
and/CC
early/JJ
time/NN
points/NNS
./.
=====
Activation/NN
also/RB
induced/VBD
c-rel/NN
and/CC
p105/p50/NN
mRNA/NN
synthesis/NN
,/,
but/CC
not/RB
p65/NN
mRNA/NN
whose/WP$
expression/NN
was/VBD
constitutive/JJ
./.
=====
Interestingly/RB
,/,
all/PDT
those/DT
early/JJ
and/CC
late/JJ
events/NNS
,/,
but/CC
not/RB
the/DT
immediate/JJ
ones/NNS
,/,
were/VBD
inhibited/VBN
by/IN
a/DT
neutralizing/VBG
anti-tumor/JJ
necrosis/NN
factor/NN
alpha/NN
(/(
TNF-alpha/NN
)/)
monoclonal/JJ
antibody/NN
./.
=====
Similarly/RB
,/,
cycloheximide/NN
prevented/VBD
the/DT
p65/NN
and/CC
c-rel/NN
translocation/NN
and/CC
consequent/JJ
formation/NN
of/IN
active/JJ
binding/NN
heterodimers/NNS
,/,
at/IN
early/JJ
and/CC
late/JJ
times/NNS
./.
=====
Cyclosporin/NN
A/NN
impaired/VBD
not/RB
only/RB
early/JJ
and/CC
late/JJ
,/,
but/CC
also/RB
immediate/JJ
events/NNS
;/:
however/RB
,/,
addition/NN
of/IN
TNF-alpha/NN
prevented/VBD
all/DT
inhibition/NN
./.
=====
These/DT
results/NNS
indicate/VBP
that/IN
the/DT
regulation/NN
of/IN
NF-kappa/NN
B/NN
activation/NN
during/IN
T/NN
cell/NN
activation/NN
by/IN
TcR/CD3/NN
signals/NNS
is/VBZ
biphasic/JJ
:/:
TcR/CD3/NN
triggers/VBZ
its/PRP$
immediate/JJ
translocation/NN
,/,
which/WDT
is/VBZ
transient/JJ
if/IN
no/DT
TNF-alpha/NN
is/VBZ
present/JJ
./.
=====
TNF-alpha/NN
,/,
therefore/RB
,/,
emerges/VBZ
as/IN
the/DT
main/JJ
factor/NN
responsible/JJ
for/IN
a/DT
second/JJ
phase/NN
of/IN
NF-kappa/NN
B/NN
regulation/NN
,/,
controlling/VBG
both/CC
translocation/NN
of/IN
p65/NN
and/CC
c-rel/NN
,/,
and/CC
new/JJ
mRNA/NN
synthesis/NN
for/IN
c-rel/NN
and/CC
p105/p50/NN
./.